Normal BMI Doesn't Mean You're Safe from Obesity's Health Risks
Over 26% of normal-BMI adults meet new clinical obesity criteria. Here's what that means for your health.
Summary
A major national study found that more than one in four U.S. adults with a normal BMI actually meet new clinical obesity criteria developed by the Lancet Diabetes and Endocrinology commission. The new framework goes beyond BMI by requiring at least one additional body measurement — like waist circumference or waist-to-height ratio — plus evidence of organ or physical dysfunction. When researchers applied this broader definition, obesity prevalence nearly doubled compared to BMI-only assessments. This matters because excess body fat, even in lean-looking individuals, can silently drive hypertension, joint problems, chronic fatigue, and other conditions. The findings suggest millions of Americans may be missing critical health interventions simply because their BMI looks normal.
Detailed Summary
For decades, BMI has been the default tool for diagnosing obesity, but a growing body of evidence — and now a major national study — suggests it misses a substantial portion of people carrying dangerous levels of body fat. Published in the Annals of Internal Medicine and led by researchers at the University of Southern California, this cross-sectional study applied a new diagnostic framework proposed by the Lancet Diabetes and Endocrinology commission in January 2025 to a nationally representative U.S. adult sample.
The core finding is striking: 26.1% of adults with a normal BMI (18.5–24.9) met the commission's criteria for clinical obesity. That figure climbed to 50.3% among those classified as overweight by BMI. When excess adiposity was defined using two or three abnormal body measurements — such as waist circumference, waist-to-hip ratio, or waist-to-height ratio — 78% of all adults qualified, nearly double the rate detected by BMI alone.
The Lancet commission's framework distinguishes between clinical obesity, defined as excess adiposity causing active organ or tissue dysfunction (including hypertension, knee pain, or chronic fatigue), and pre-clinical obesity, where excess fat is present but not yet causing measurable harm. This distinction is clinically important: it identifies people who need intervention now versus those who need monitoring.
For health-conscious individuals, the practical takeaway is clear. A normal BMI is not a green light. Body composition metrics — particularly waist measurements and ideally DEXA or bioimpedance testing — offer a more accurate picture of metabolic risk. Someone with low muscle mass and a normal weight may carry enough visceral fat to drive serious disease processes.
Important caveats remain. This is a cross-sectional study, meaning causality cannot be established. Researchers themselves called for follow-up studies to confirm whether applying this new framework actually improves health outcomes. The new criteria may also increase diagnostic rates significantly, raising questions about healthcare capacity and potential overdiagnosis.
Key Findings
- 26% of normal-BMI U.S. adults met new Lancet commission criteria for clinical obesity in this national study.
- 78% of all adults showed excess adiposity when two or three body measurements were used instead of BMI alone.
- The new framework requires BMI plus waist circumference, waist-to-hip ratio, or DEXA scan for accurate obesity diagnosis.
- Clinical obesity is defined as excess fat actively causing dysfunction like hypertension, joint pain, or fatigue — not just high weight.
- Researchers urge follow-up studies to confirm whether the new diagnostic criteria actually improve patient health outcomes.
Methodology
This is a news report summarizing a peer-reviewed cross-sectional study published in the Annals of Internal Medicine, led by researchers at the University of Southern California. The study applied the Lancet Diabetes and Endocrinology commission's 2025 diagnostic framework to a nationally representative U.S. adult sample. Cross-sectional design limits causal inference.
Study Limitations
Cross-sectional design means the study cannot establish whether the new diagnostic criteria lead to better health outcomes, which researchers acknowledged as an open question. The Lancet commission framework is newly proposed and not yet standard clinical practice, so long-term validation data are lacking. Readers should consult the primary Annals of Internal Medicine publication for full methodology and population details.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.